Minhhuyen Nguyen is a Gastroenterology physician affiliated with Fox Chase Cancer Center. OpenAlex indexes 33 publications with 789 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
333 Cottman Ave
Fox Chase Cancer Center
Philadelphia, PA 191112434
Telephone
215-728-6900Registry record last updated 9 Apr 2018.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20257 payments$12,406openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year20242 payments$10,700openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
62%Proton pump inhibitor33.1%Pantoprazole Sodium75%Omeprazole14%Esomeprazole Magnesium11%Part D<11 patientsH2 blocker7.6%Famotidine100%Part D≥28 patients+ 7 more classes in this area
Anti-infectives
17.7%Nucleoside and nucleotide reverse transcriptase inhibitors15.6%Tenofovir Disoproxil Fumarate61%Vemlidy39%Part D<11 patientsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor2.1%Entecavir100%Part D<11 patientsCardiovascular
9.2%Beta blocker3.6%Carvedilol100%Part D<11 patientsBile Acid Sequestrant2.2%Colestipol Hcl100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Multilevel and multicomponent intervention to promote colorectal cancer screening among Vietnamese Americans: a cluster randomized trial
Translational Behavioral Medicine
2025 - Abstract B085: Promoting colorectal cancer screening among underserved Vietnamese Americans through a multilevel community-based randomized controlled trial
Cancer Epidemiology Biomarkers & Prevention
2024 - Abstract B109: Depression is a risk factor for noncompliance with antiviral medication treatment among Asian Americans with chronic hepatitis B
Cancer Epidemiology Biomarkers & Prevention
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Elizabeth Plimack, MD
Fox Chase Cancer Center
Martin Edelman, MD
Fox Chase Cancer Center
Shazia Nakhoda, MD
Fox Chase Cancer Center
Hossein Borghaei, MD
Fox Chase Cancer Center
Charles Rice, MD
The Rockefeller University
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
Kris Kowdley, MD
Washington State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”